loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 18723 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    AbbVie Inc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 ABBVIE (3)

    filter

    01 TABLET, DELAYED RELEASE;ORAL (3)

    filter

    01 RX (3)

    filter

    01 DEPAKOTE (3)

    filter

    01 Yes (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DIVALPROEX SODIUM

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, DELAYED RE...
    EQ 125MG VALPROIC ...
    1984-10-26
    18723
    DEPAKOTE
    RX
    Yes
    AB
    Abbvie Company Banner

    Cophex 2024

    Not Confirmed

    envelop Contact Supplier
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DIVALPROEX SODIUM

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, DELAYED RE...
    EQ 250MG VALPROIC ...
    1983-03-10
    18723
    DEPAKOTE
    RX
    Yes
    AB
    Abbvie Company Banner

    Cophex 2024

    Not Confirmed

    envelop Contact Supplier
    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Contact Supplier Contact Supplier
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DIVALPROEX SODIUM

    PDF Supplier PDF
    URL Supplier Web Content
    TABLET, DELAYED RE...
    EQ 500MG VALPROIC ...
    1983-03-10
    18723
    DEPAKOTE
    RX
    Yes
    AB
    Abbvie Company Banner

    Cophex 2024

    Not Confirmed

    envelop Contact Supplier

    Looking for FDA Orange Book APPLICATION 18723

    Looking for FDA Orange Book APPLICATION 18723 3

    19

    AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is DIVALPROEX SODIUM, with a corresponding application number 18723.

    Regulatory Information RX

    With a dosage strength EQ 125MG VALPROIC ACID

    Dosage Form Route TABLET, DELAYED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 1984-10-26

    Therapeutic Equivalence (TE) Code AB

    18

    AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is DIVALPROEX SODIUM, with a corresponding application number 18723.

    Regulatory Information RX

    With a dosage strength EQ 250MG VALPROIC ACID

    Dosage Form Route TABLET, DELAYED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 1983-03-10

    Therapeutic Equivalence (TE) Code AB

    17

    AbbVie Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is DIVALPROEX SODIUM, with a corresponding application number 18723.

    Regulatory Information RX

    With a dosage strength EQ 500MG VALPROIC ACID

    Dosage Form Route TABLET, DELAYED RELEASE; ORAL

    Reference Listed Drug Yes

    Approved since 1983-03-10

    Therapeutic Equivalence (TE) Code AB

    Post Enquiry
    POST ENQUIRY